March 10, 2020
Industry Non-CME Program Lineup AnnouncedThis year’s Industry Non-CME (INC) Programs, March 19-22, are held concurrently during the AAD 2020 Annual Meeting. At the sponsoring company’s discretion, these sessions present new research findings, showcase specialty innovations, conduct demonstrations, and host lively discussions. These informational programs do not qualify for CME credit. > MORE - Looking Beyond the Skin: How to Better Assess Atopic Dermatitis to Improve Care for Your PatientsProgram overview: This program will provide clinicians with an overview of scales used to assess signs and symptoms of atopic dermatitis, followed by an in-depth discussion of scales that can be used to assess the multidimensional burden of the disease. > MORE
- Let’s Talk About an Option for Your Patients with Challenging Manifestations of PsoriasisProgram overview: An engaging presentation on a treatment option for patients with moderate to severe plaque psoriasis with involvement of difficult to treat areas, who are candidates for phototherapy or systemic therapy. > MORE
- Cosmetic Treatment of HyperpigmentationProgram overview: In this Industry Non-CME program, expert scientists and dermatologists will discuss the biology of hyperpigmentation, which is a global skincare concern and one of the most challenging skin conditions to address. > MORE
- Beyond Skin DeepProgram overview: Join The Atlantic for an evening of conversations with patients and medical experts discussing how skin conditions can affect physical and mental health. > MORE
- A Virtual Reality View: Pediatric & Adolescent Patients with Moderate-to-Severe Atopic DermatitisProgram overview: While guidelines regarding the management of AD in children have been published, variability persists in practice. Treatment inconsistencies and the chronic and relapsing nature of AD can lead to frustration for patients, family, and caregivers when managing AD. > MORE
- New Frontiers in Psoriasis: Evolving Treatment Goals, Patient Expectations, and Therapeutic TargetsProgram overview: An educational symposium discussing evolving expectations in the treatment of psoriasis and how to measure the success of treatment for the patient as well as expert insights into how the IL-17 family of cytokines may be essential to addressing the complexities of the disease. > MORE
- Live Medical Crossfire: How Do Recent Pathophysiological Findings in Pustular Psoriasis Have the Potential to Shape a New Treatment Paradigm?Program overview: Pustular psoriasis outbreaks can be severe and life-threatening but early diagnosis is hindered by its rarity, heterogeneous presentation, and lack of consistent classification. > MORE
- A Timely Intervention: Early Clues to Identify the Patient with PsO at Risk of PsAProgram overview: This program is designed to educate dermatology practitioners to diagnose PsA early in their patients with psoriasis, to recognize the preclinical indicators of PsA risk, and to help guide clinical decisions based on the PsA risk profiles of their patients in order to treat psoriatic disease with therapies that cover the spectrum of psoriatic manifestations. > MORE
- Diving Deeper into the Role of Systemic Therapy in Advanced CSCCProgram overview: For many patients with advanced cutaneous squamous cell carcinoma (CSCC), surgery just isn’t enough. Let's take a deeper dive into the clinical data to explore when systemic therapy should be considered. > MORE
- Innovation in Psoriasis Research: Steps Toward A Patient-Centered ApproachProgram overview: This Bristol-Myers Squibb-sponsored dialectic symposium, led by dermatology experts, will focus on innovative approaches to psoriasis research. > MORE
